UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Kayser–Fleischer ring in Wilson's disease: A cohort study

European journal of internal medicine, 2012-09, Vol.23 (6), p.e150-e156

2012

Volltextzugriff (PDF)

Quality of Life and Psychiatric Symptoms in Wilson's Disease: the Relevance of Bipolar Disorders

Clinical practice and epidemiology in mental health, 2012, Vol.8 (1), p.102-109

2012

Volltextzugriff (PDF)

Retrospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment with Trientine in Wilson Disease Patients Withdrawn from Therapy with D-Penicillamine

Journal of hepatology, 2016, Vol.64 (2), p.S293-S293

2016

Volltextzugriff (PDF)

HBV and HCV infections in Wilson's disease patients: Copper overload could be protective?

Clinical biochemistry, 2012-09, Vol.45 (13-14), p.1095-1096

2012

Volltextzugriff (PDF)

SAT0297 Non-Invasive Assessment of Silent Liver Fibrosis in Patients with Systemic Sclerosis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.700-700

2014

Volltextzugriff (PDF)

P.15.8 UNEVEN DISTRIBUTION OF HEPATIC COPPER CONCENTRATION AND DIAGNOSTIC VALUE OF DOUBLE BIOPSY SAMPLES BIOPSY IN WILSON'S DISEASE

Digestive and liver disease, 2012-03, Vol.44, p.S186-S186

2012

Volltextzugriff (PDF)

Transient elastography in patients with chronic autoimmune hepatitis: is a good tool in evaluation of hepatic fibrosis?

Digestive and liver disease, 2015-02, Vol.47, p.e64-e64

2015

Volltextzugriff (PDF)

Value of histochemical stains for copper in the diagnosis of Wilson's disease

Histopathology, 1998-07, Vol.33 (1), p.28-33

1998

Volltextzugriff (PDF)

[54] PEGINTERFERON-ALPHA-2a PLUS ADEFOVIR VS. PEGINTERFERON ALPHA-2a FOR 48 WEEKS IN HBeAg-NEGATIVE CHRONIC HEPATITIS B: PRELIMINARY 24-WEEK RESULTS OF THE PEG FOR B RANDOMIZED MULTICENTER TRIAL

Journal of hepatology, 2007, Vol.46, p.S26-S26

2007

Volltextzugriff (PDF)

A randomized controlled trial of pegylated interferon- alpha 2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B

Antiviral therapy, 2009-01, Vol.14 (8), p.1165-1174

2009

Volltextzugriff (PDF)

Comparison of MRI, EEG, EPs and ECD-SPECT in Wilson's disease

Acta neurologica Scandinavica, 2001-02, Vol.103 (2), p.71-81

2001

Volltextzugriff (PDF)

Massive hepatic haemosiderosis in Wilson's disease

Histopathology, 2000-08, Vol.37 (2), p.187-189

2000

Volltextzugriff (PDF)

A randomized controlled trial of amantadine plus interferon‐α2a vs. interferon‐α2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon‐α2a monotherapy

Alimentary pharmacology & therapeutics, 2004-02, Vol.19 (3), p.339-347

2004

Volltextzugriff (PDF)

THU-485 - Retrospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment with Trientine in Wilson Disease Patients Withdrawn from Therapy with D-Penicillamine

Journal of hepatology, 2016, Vol.64 (2), p.S293-S293

2016

Volltextzugriff (PDF)

TT virus infection in Italy: prevalence and genotypes in healthy subjects, viral liver diseases and asymptomatic infections by parenterally transmitted viruses

Journal of viral hepatitis, 2001-09, Vol.8 (5), p.384-390

2001

Volltextzugriff (PDF)

A randomized controlled trial of sequential peginterferon-alpha and telbivudine or vice versa for 48 weeks in HBeAg-negative chronic hepatitis B

Antiviral therapy, 2012-01, Vol.18 (1)

2012

Volltextzugriff (PDF)

Wilson's disease with late onset

Digestive and liver disease, 2000-03, Vol.32 (2), p.180-180

2000

Volltextzugriff (PDF)

Clinical features of Wilson's disease in Sardinia

Journal of clinical virology, 2006-01, Vol.36, p.S216-S216

2006

Volltextzugriff (PDF)

P.504 Clinical features of Wilson's disease in Sardinia

Journal of clinical virology, 2006, Vol.36, p.S216-S216

2006

Volltextzugriff (PDF)

664 HFE gene mutations and Wilson's disease in Sardinia

Journal of hepatology, 2006-04, Vol.44, p.S245-S245

2006

Volltextzugriff (PDF)

HCV Transmission in Family Members of Subjects with HCV Related Chronic Liver Disease

European journal of epidemiology, 1996-02, Vol.12 (1), p.45-50

1996

Volltextzugriff (PDF)

Predictive testing for Wilson's disease using tightly linked and flanking DNA markers

Neurology, 1991-07, Vol.41 (7), p.992

1991

Volltextzugriff (PDF)

Uneven hepatic copper distribution in Wilson's disease

Journal of hepatology, 1995-03, Vol.22 (3), p.303-308

1995

Volltextzugriff (PDF)

Correspondence

Histopathology, 2001-09, Vol.39 (3), p.323-323

2001

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(52)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(26)
Adult
(24)
Male
(22)
Female
(18)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Middle Aged
(16)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Adolescent
(10)
Aged
(9)
Gastroenterology & Hepatology
(7)
Infectious Diseases
(7)
Metabolic Diseases
(7)
Metals
(7)
Other Metabolic Disorders
(7)
Hepatolenticular Degeneration - Pathology
(6)
Wilson's Disease
(6)
Hepatolenticular Degeneration - Diagnosis
(5)
Liver - Pathology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Add‐on peginterferon alfa‐2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen‐negative chronic hepatitis B genotype D

Kayser–Fleischer ring in Wilson's disease: A cohort study

Quality of Life and Psychiatric Symptoms in Wilson's Disease: the Relevance of Bipolar Disorders

Retrospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment with Trientine in Wilson Disease Patients Withdrawn from Therapy with D-Penicillamine

HBV and HCV infections in Wilson's disease patients: Copper overload could be protective?

SAT0297 Non-Invasive Assessment of Silent Liver Fibrosis in Patients with Systemic Sclerosis

P.15.8 UNEVEN DISTRIBUTION OF HEPATIC COPPER CONCENTRATION AND DIAGNOSTIC VALUE OF DOUBLE BIOPSY SAMPLES BIOPSY IN WILSON'S DISEASE

Transient elastography in patients with chronic autoimmune hepatitis: is a good tool in evaluation of hepatic fibrosis?

Value of histochemical stains for copper in the diagnosis of Wilson's disease

[54] PEGINTERFERON-ALPHA-2a PLUS ADEFOVIR VS. PEGINTERFERON ALPHA-2a FOR 48 WEEKS IN HBeAg-NEGATIVE CHRONIC HEPATITIS B: PRELIMINARY 24-WEEK RESULTS OF THE PEG FOR B RANDOMIZED MULTICENTER TRIAL

A randomized controlled trial of pegylated interferon- alpha 2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B

Comparison of MRI, EEG, EPs and ECD-SPECT in Wilson's disease

Massive hepatic haemosiderosis in Wilson's disease

A randomized controlled trial of amantadine plus interferon‐α2a vs. interferon‐α2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon‐α2a monotherapy

THU-485 - Retrospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment with Trientine in Wilson Disease Patients Withdrawn from Therapy with D-Penicillamine

TT virus infection in Italy: prevalence and genotypes in healthy subjects, viral liver diseases and asymptomatic infections by parenterally transmitted viruses

A randomized controlled trial of sequential peginterferon-alpha and telbivudine or vice versa for 48 weeks in HBeAg-negative chronic hepatitis B

Wilson's disease with late onset

Clinical features of Wilson's disease in Sardinia

P.504 Clinical features of Wilson's disease in Sardinia

664 HFE gene mutations and Wilson's disease in Sardinia

HCV Transmission in Family Members of Subjects with HCV Related Chronic Liver Disease

Predictive testing for Wilson's disease using tightly linked and flanking DNA markers

Uneven hepatic copper distribution in Wilson's disease

Correspondence

Suchergebnisse filtern